Cardiac troponin I levels after cardiac surgery as predictor for in-hospital mortality
- PMID: 20008898
- DOI: 10.1510/icvts.2009.216408
Cardiac troponin I levels after cardiac surgery as predictor for in-hospital mortality
Abstract
Purpose: Troponin is a specific marker of myocardial damage. Increased troponins, however, are observed after almost all cardiac surgery. The clinical significance of this elevation is controversial. The aim of this study was to evaluate if troponin I (cTnI) measured 1 h after cardiac surgery provides additional information to identify patients at risk for hospital mortality.
Methods: Nine hundred and thirty-eight patients undergoing cardiac surgery between October 2006 and June 2008 served as development set. This group included 688 isolated CABGs and 250 valvular (+CABG) operations, and cTnI levels were measured 1 h (cTnI) after surgery. Hospital mortality, defined as death occurring at the Radboud University Nijmegen Medical Centre (UMCN) at any time after surgery, is the studied outcome. To assess the value of cTnI as a predictor for hospital mortality, receiver-operator characteristic (ROC) curves were used. The Youden-index was used for identifying the best cut-off point. Five hundred and seventy-nine patients undergoing cardiac surgery between July 2008 and February 2009 served as validation set.
Results: The median cTnI level was 1.3 microg/l, 75% inter-quartile range (IQR) 0.68-2.59 microg/l. Ten patients (1.1%) died, cTnI release of the dead, median: 6.8 microg/l was significantly higher than the measured values in the group of survivors, median: 1.3 microg/l (P<0.001). Regression analysis showed a significant correlation between cTnI and hospital mortality (P<0.001). The ROC indicates a cTnI level of 4.25 microg/l with a ROC of 0.80 as optimal cut-off point for predicting hospital mortality, with a sensitivity of 70% and a specificity of 89%. Addition of type of surgery, isolated CABG vs. valve surgery, acute vs. elective surgery and EuroSCORE class did not improve the ROCs. In the validation set, the median cTnI level was 1.17 microg/l. Fifty-six patients had a cTnI level >4.25 microg/l. Of the 579 patients, 11 patients (1.8%) died, six of them had a cTnI level >4.25 microg/l.
Conclusion: Postoperative cTnI level, measured within the first hour after cardiac surgery, can identify a subgroup of patients with increased risk for hospital mortality. These patients may benefit from better monitoring, eventually with specific diagnostic and therapeutic interventions.
Comment in
-
Is early assessment of cardiac troponin I a valuable predictor of mortality after cardiac surgery?Interact Cardiovasc Thorac Surg. 2010 Mar;10(3):416-7. doi: 10.1510/icvts.2009.216408A. Interact Cardiovasc Thorac Surg. 2010. PMID: 20185847 No abstract available.
Similar articles
-
Comparison of cardiac troponin I versus T and creatine kinase MB after coronary artery bypass grafting in patients with and without perioperative myocardial infarction.Herz. 2004 Nov;29(7):658-64. doi: 10.1007/s00059-004-2543-y. Herz. 2004. PMID: 15580320 Clinical Trial.
-
Troponin after cardiac surgery: a predictor or a phenomenon?Ann Thorac Surg. 2008 Apr;85(4):1348-54. doi: 10.1016/j.athoracsur.2007.12.077. Ann Thorac Surg. 2008. PMID: 18355525
-
Risk stratification with cardiac troponin I in patients undergoing elective coronary artery bypass surgery.Eur J Cardiothorac Surg. 2005 May;27(5):861-9. doi: 10.1016/j.ejcts.2005.01.043. Eur J Cardiothorac Surg. 2005. PMID: 15848327
-
Is brain natriuretic peptide a marker for adverse postoperative outcomes in patients undergoing cardiac surgery?Interact Cardiovasc Thorac Surg. 2011 Mar;12(3):467-72. doi: 10.1510/icvts.2010.252601. Epub 2010 Dec 24. Interact Cardiovasc Thorac Surg. 2011. PMID: 21186284 Review.
-
[Circulating troponin I assay: uses and misuses in medical practice].Rev Med Interne. 2003 Sep;24(9):623-6. doi: 10.1016/s0248-8663(03)00228-5. Rev Med Interne. 2003. PMID: 12951185 Review. French.
Cited by
-
ESC Joint Working Groups on Cardiovascular Surgery and the Cellular Biology of the Heart Position Paper: Perioperative myocardial injury and infarction in patients undergoing coronary artery bypass graft surgery.Eur Heart J. 2017 Aug 14;38(31):2392-2407. doi: 10.1093/eurheartj/ehx383. Eur Heart J. 2017. PMID: 28821170 Free PMC article. No abstract available.
-
Protective effect of dexmedetomidine in coronary artery bypass grafting surgery.Exp Ther Med. 2013 Aug;6(2):497-502. doi: 10.3892/etm.2013.1183. Epub 2013 Jun 25. Exp Ther Med. 2013. PMID: 24137215 Free PMC article.
-
Levosimendan and mortality after coronary revascularisation: a meta-analysis of randomised controlled trials.Crit Care. 2011 Jun 8;15(3):R140. doi: 10.1186/cc10263. Crit Care. 2011. PMID: 21651806 Free PMC article.
-
Prognostic value of high-sensitivity cardiac troponin in non-cardiac surgical patients in intensive care units.Intern Emerg Med. 2024 Jan;19(1):201-209. doi: 10.1007/s11739-023-03509-z. Epub 2024 Jan 9. Intern Emerg Med. 2024. PMID: 38194002 Free PMC article.
-
A review of cardiac troponin I detection by surface enhanced Raman spectroscopy: Under the spotlight of point-of-care testing.Front Chem. 2022 Oct 13;10:1017305. doi: 10.3389/fchem.2022.1017305. eCollection 2022. Front Chem. 2022. PMID: 36311415 Free PMC article. Review.
Publication types
MeSH terms
Substances
LinkOut - more resources
Full Text Sources
Medical
Research Materials